Health
CRISPR-Cas9 Editing Can Favor Cancer-Linked KRAS Genes – Clinical OMICs News
Clinical trials based on CRISPR technology have been deferred due to potential risks, such as off-target effects, the creation…
Highlighting the need to monitor patients who have undergone CRISPR-Cas9-based gene therapy for cancer-related mutations, researchers at Sanford Burnham Prebys have shown that gene editing, specifically gene knockout (KO) using CRISPR-Cas9 technology, can…
Continue Reading
-
General11 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
Noosa News18 hours agoPrime Minister Anthony Albanese calls for political temperature to be ‘turned down’ after alleged death threat
-
Business23 hours agoWhy this speculative ASX stock is jumping 6% today
-
Noosa News13 hours agoPerth Royal Show attendance slumps to 10-year low